Novel phenyl-urea derivatives as dual-target ligands that can activate both GK and PPARγ

Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, 414, 799, 10.1038/414799a Zhang, 2012, Berberine in type 2 diabetes therapy: a new perspective for an old antidiarrheal drug?, Acta Pharm Sin B, 2, 378, 10.1016/j.apsb.2012.06.004 Matschinsky, 1998, Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities, Diabetes, 47, 307, 10.2337/diabetes.47.3.307 Grimsby, 2003, Allosteric activators of glucokinase: potential role in diabetes therapy, Science, 301, 370, 10.1126/science.1084073 Moller, 2001, New drug targets for type 2 diabetes and the metabolic syndrome, Nature, 414, 821, 10.1038/414821a Moller, 2001, Peroxisome proliferator-activated receptor (PPAR) agonists for diabetes, Adv Protein Chem, 56, 181, 10.1016/S0065-3233(01)56006-4 Ye, 2011, Challenges in drug discovery for thiazolidinedione substitute, Acta Pharm Sin B, 1, 137, 10.1016/j.apsb.2011.06.011 Ushiroda, 2011, Synthesis and pharmacological evaluation of novel benzoylazole-based PPARα/γ activators, Bioorg Med Chem Lett, 21, 1978, 10.1016/j.bmcl.2011.02.032 Kumari, 2008, Comparative docking assessment of glucokinase interactions with its allosteric activators, Curr Chem Genomics, 2, 76, 10.2174/1875397300802010076 Bahn, 2005, Carbonic anhydrase and CO2 sensing during Cryptococcus neoformans growth, differentiation, and virulence, Curr Biol, 15, 2013, 10.1016/j.cub.2005.09.047 Ishikawa, 2009, Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators, Bioorg Med Chem Lett, 19, 4450, 10.1016/j.bmcl.2009.05.038 Pfefferkorn, 2009, Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle, Bioorg Med Chem Lett, 12, 3247, 10.1016/j.bmcl.2009.04.107 Grimsby, 2008, Glucokinase activators for the potential treatment of type 2 diabetes, Curr Top Med Chem, 8, 1524, 10.2174/156802608786413483 Kamata, 2004, Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase, Structure, 12, 429, 10.1016/j.str.2004.02.005